Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Probenecid in Fontan Circulation
NCT03965351Phase 4Completed
- Sponsor
- Cincinnati Children's Hospital Medical Center
- Start
- Mar 2017
- Primary completion
- Jun 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in Fontan circulation comparing Probenecid First with Placebo First (2 arms). Primary endpoints: End Diastolic Volume at 12 weeks and End Systolic Volume at 12 weeks. Started Mar 2017; status: completed.
02
Drugs
probenecid
03
Conditions
Fontan circulation
Beyond the preview
Go deeper on NCT03965351.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03965351.